Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination

B. G M Van Engelen, Kevin D. Pavelko, Moses Rodriguez

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.

Original languageEnglish (US)
Pages (from-to)76-79
Number of pages4
JournalMultiple Sclerosis
Volume3
Issue number2
StatePublished - Apr 1997

Fingerprint

Demyelinating Diseases
Theoretical Models
Central Nervous System
Myelin Sheath
Immunoglobulins
Theilovirus
Lysophosphatidylcholines
Passive Immunization
Poisons
Immunosuppression
Immune System

Keywords

  • CNS
  • Demyelination
  • Experimental models
  • Humans
  • Immunoglobulin
  • Remyelination

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. / Van Engelen, B. G M; Pavelko, Kevin D.; Rodriguez, Moses.

In: Multiple Sclerosis, Vol. 3, No. 2, 04.1997, p. 76-79.

Research output: Contribution to journalArticle

Van Engelen, B. G M ; Pavelko, Kevin D. ; Rodriguez, Moses. / Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. In: Multiple Sclerosis. 1997 ; Vol. 3, No. 2. pp. 76-79.
@article{66963022c5c54487abe1529ec4b1a42e,
title = "Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination",
abstract = "Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.",
keywords = "CNS, Demyelination, Experimental models, Humans, Immunoglobulin, Remyelination",
author = "{Van Engelen}, {B. G M} and Pavelko, {Kevin D.} and Moses Rodriguez",
year = "1997",
month = "4",
language = "English (US)",
volume = "3",
pages = "76--79",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination

AU - Van Engelen, B. G M

AU - Pavelko, Kevin D.

AU - Rodriguez, Moses

PY - 1997/4

Y1 - 1997/4

N2 - Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.

AB - Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.

KW - CNS

KW - Demyelination

KW - Experimental models

KW - Humans

KW - Immunoglobulin

KW - Remyelination

UR - http://www.scopus.com/inward/record.url?scp=0030750808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030750808&partnerID=8YFLogxK

M3 - Article

C2 - 9291157

AN - SCOPUS:0030750808

VL - 3

SP - 76

EP - 79

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 2

ER -